USPTO trademark

KRINGLE PHARMA

Under examinationUSPTOWord markClass 5Class 42

"KRINGLE PHARMA" is a word mark owned by Kringle Pharma, Inc., filed at the USPTO on July 31, 2026. It is under examination and covers classes 5 and 42.

View Kringle Pharma, Inc. portfolioGet this data via the API
Official USPTO record
KRINGLE PHARMA trademark as filed
As filed with the USPTO
Status
Under examination
Since July 31, 2026
Filed
July 31, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50024662
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns KRINGLE PHARMA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Kringle Pharma, Inc.

Osaka-shi, Osaka, Japan

21 trademarks in the portfolioView company

Representative

Kumiko Ide

Wenderoth, Lind & Ponack, LLP

Goods and services

What the mark covers

The products and services KRINGLE PHARMA is filed for, grouped by Nice class.

  • Pharmaceutical and veterinary preparations for the treatment of liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer; pharmaceutical preparations acting on the peripheral nervous system; cardiovascular treatment preparations; capillary stabilizers, namely, pharmaceutical preparations for stabilizing capillaries; cerebral hemorrhage prophylactic preparations; pharmaceutical preparations acting on respiratory organs for treating respiratory illnesses and conditions; pharmaceutical preparations acting on digestive organs for treating ulcers and digestive conditions; pharmaceutical preparations for dental purposes for treating and preventing gingivostomatitis, alveolar abscess, and alveoloclasia; pharmaceutical preparations acting on uro-genital and anal organs for treating urinary and anal gland related illnesses and conditions; medicated skin care preparations; astringents for medical purposes; anti-inflammatory agents; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, and lupus erhthematosus; hemostatics for medical purposes; pharmaceutical preparations affecting metabolism; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for treating physically caused lesions; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disorders, namely, for treating chemical burns, side effects of anticancer drugs, and side effects of immunosuppresants; biological preparations for medical purposes, namely, biological tissue grafts

  • Testing, inspection or research of pharmaceuticals and genetics; medical research; consultancy and providing testing, inspection and research information services in the field of testing, inspection or research of pharmaceuticals and genetics; consultancy and providing research information services in the field of medical research; providing medical research and scientific research information and advice in the fields of pharmaceuticals and genetics

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. New application office supplied data entered
  2. Application filing receipt mailed
  3. New application entered
FAQ

About KRINGLE PHARMA

Who owns the trademark "KRINGLE PHARMA"?

The USPTO trademark "KRINGLE PHARMA" (application 50024662) is owned by Kringle Pharma, Inc.

What is the status of "KRINGLE PHARMA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull KRINGLE PHARMA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019fbd6d-751f-76f6-a26f-6c717a33bfab
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019fbd6d-751f-76f6-a26f-6c717a33bfab",
  "object": "trademark",
  "mark_text": "KRINGLE PHARMA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50024662",
  "filing_date": "2026-07-31",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "KRINGLE PHARMA, INC.",
      "entity_id": "ent_019eb7be-ee75-719d-83c9-7908297e9223"
    }
  ]
}